|
"yen cj"的相關文件
顯示項目 26-35 / 99 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2020-08 |
Investigating the health disparities in the association between lifestyle behaviors and the risk of head and neck cancer
|
Hsiao, JR;Huang, CC;Ou, CY;Chang, CC;Lee, WT;Tsai, ST;Huang, JS;Chen, KC;Lai, YH;Wu, YH;Hsueh, WT;Wu, SY;Yen, CJ;Chang, JY;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2020-05-28 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang, NJ;Chen, MH;Yang, SH;Hsu, C;Yen, CJ;Tsou, HH;Su, YY;Chen, JS;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2020-05-26 |
Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan
|
Shan, YS;Chen, LT;Wu, JS;Chang, YF;Lee, CT;Wu, CH;Chiang, NJ;Huang, HE;Yen, CJ;Chao, YJ;Tsai, HJ;Chen, CY;Kang, JW;Kuo, CF;Tsai, CR;Weng, YL;Yang, HC;Liu, HC;Chang, JS |
| 國家衛生研究院 |
2020-05-04 |
The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort
|
Su, YY;Chiang, NJ;Tsai, HJ;Yen, CJ;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2020-04 |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
de Bono, J;Lin, CC;Chen, LT;Corral, J;Michalarea, V;Rihawi, K;Ong, M;Lee, JH;Hsu, CH;Yang, JC;Shiah, HS;Yen, CJ;Anthoney, A;Jove, M;Buschke, S;Fuertig, R;Schmid, U;Goeldner, RG;Strelkowa, N;Huang, DC;Bogenrieder, T;Twelves, C;Cheng, AL |
| 國家衛生研究院 |
2020-03-10 |
Dishevelled 1-regulated superpotent cancer stem cells mediate wnt heterogeneity and tumor progression in hepatocellular carcinoma
|
Liao, WY;Hsu, CC;Chan, TS;Yen, CJ;Chen, WY;Pan, HW;Tsai, KK |
| 國家衛生研究院 |
2020-03-01 |
A selective Aurora-A 5'-UTR siRNA inhibits tumor growth and metastasis
|
Lai, CH;Chen, RY;Hsieh, HP;Tsai, SJ;Chang, KC;Yen, CJ;Huang, YC;Liu, YW;Lee, JC;Lai, YC;Hung, LY;Lin, BW |
| 國家衛生研究院 |
2020-03 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: A TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen, LT;Martinelli, E;Cheng, AL;Pentheroudakis, G;Qin, S;Bhattacharyya, GS;Ikeda, M;Lim, HY;Ho, GF;Choo, SP;Ren, Z;Malhotra, H;Ueno, M;Ryoo, BY;Kiang, TC;Tai, D;Vogel, A;Cervantes, A;Lu, SN;Yen, CJ;Huang, YH;Chen, SC;Hsu, C;Shen, YC;Tabernero, J;Yen, Y;Hsu, CH;Yoshino, T;Douillard, JY |
| 中山醫學大學 |
2020 |
Satisfaction with pain management and impact of pain on quality of life in cancer patients
|
Lin, JS; Hsieh, RK; Chen, JS; Lee, KD; Rau, KM; Shao, YY; Sung, YC; Yeh, SP; Chang, CS; Liu, TC; Wu, MF; Lee, MY; Yu, MS; Yen, CJ; Lai, PY; Hwang, WL; Chiou, TJ |
| 國家衛生研究院 |
2019-10-05 |
Percutaneous computed tomography-guided coaxial core biopsy for the diagnosis of pancreatic tumors
|
Su, YY;Liu, YS;Chao, YJ;Chiang, NJ;Yen, CJ;Tsai, HM |
顯示項目 26-35 / 99 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
